{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:53:26Z","timestamp":1791273206052,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lungcan.2026.109552","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:05:24Z","timestamp":1785103524000},"page":"109552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating health-related quality of life questionnaires in capturing common symptomatic adverse events in non-small cell lung cancer"],"prefix":"10.1016","volume":"219","author":[{"given":"Lotte","family":"van der Weijst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-5441","authenticated-orcid":false,"given":"Cecilia","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9437-8787","authenticated-orcid":false,"given":"Maria","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-2599","authenticated-orcid":false,"given":"Hayat","family":"Hamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-1227","authenticated-orcid":false,"given":"Alexandra","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3918-1174","authenticated-orcid":false,"given":"Claire","family":"Piccinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Servetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Remon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-5642","authenticated-orcid":false,"given":"Roberto","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-8699","authenticated-orcid":false,"given":"Jose","family":"Pais-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109552_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103296","article-title":"Analysis of adverse events attribution and reporting in cancer clinical trials: a systematic review","volume":"160","author":"Enrico","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lungcan.2026.109552_b0010","unstructured":"NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs, 2024."},{"key":"10.1016\/j.lungcan.2026.109552_b0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/annonc\/mdv485","article-title":"The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members","volume":"27","author":"Maillet","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0030","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/S1470-2045(22)00654-4","article-title":"Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group","volume":"24","author":"Piccinin","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lungcan.2026.109552_b0040","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.21.02017","article-title":"Linking the European organisation for research and treatment of cancer item library to the common terminology criteria for adverse events","volume":"40","author":"Gilbert","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115392","article-title":"Flexibility in patient-reported outcome and health-related quality of life measurement: the EORTC Quality of Life Group measurement strategy","volume":"220","author":"Piccinin","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2026.109552_b0050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lungcan.2022.03.010","article-title":"Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)","volume":"166","author":"Van der Weijst","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109552_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00715","article-title":"Health-related quality of life in advanced non-small cell lung cancer: a methodological appraisal based on a systematic literature review","volume":"9","author":"Van Der Weijst","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1470-2045(20)30093-0","article-title":"Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study","volume":"21","author":"Koller","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","author":"Aaronson","year":"1993","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.lungcan.2026.109552_b0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2022.09.020","article-title":"The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: results of the REQUITE study: symptoms, toxicity and quality of life of lung cancer patient","volume":"176","author":"van der Weijst","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/annonc\/mdq189","article-title":"Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and followup","volume":"21","author":"D\u2019Addario","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdq207","article-title":"Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Crin\u00f2","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","article-title":"Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0090","unstructured":"European Commission, Guideline on the packaging information of medicinal products for human use, 2023."},{"key":"10.1016\/j.lungcan.2026.109552_b0095","doi-asserted-by":"crossref","first-page":"A775","DOI":"10.1016\/j.jval.2017.08.2236","article-title":"The use of the eortc item library to supplement eortc quality of life instruments","volume":"20","author":"Kulis","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.lungcan.2026.109552_b0100","unstructured":"N. Cancer Institute, Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events (CTCAE) v5.0, 2017. https:\/\/www.meddra.org\/."},{"key":"10.1016\/j.lungcan.2026.109552_b0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline \u2606","volume":"33","author":"Di Maio","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.xjon.2022.10.001","article-title":"The value of patient-reported outcomes in lung cancer clinical trials","volume":"12","author":"Pompili","year":"2022","journal-title":"JTCVS Open"},{"key":"10.1016\/j.lungcan.2026.109552_b0115","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-024-02929-4","article-title":"Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer","volume":"30","author":"Zeng","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2026.109552_b0120","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jamaoncol.2025.3153","article-title":"Patient-reported outcomes as prognostic indicators for overall survival in cancer","volume":"11","author":"Huang","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103153","article-title":"Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study","volume":"82","author":"Lim","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.lungcan.2026.109552_b0130","doi-asserted-by":"crossref","unstructured":"P.G. Kluetz, D.T. Chingos, E.M. Basch, S.A. Mitchell, Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), 2016.","DOI":"10.1200\/EDBK_159514"},{"key":"10.1016\/j.lungcan.2026.109552_b0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMp1114649","article-title":"Toward patient-centered drug development in oncology","volume":"369","author":"Basch","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109552_b0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PROM.S156279","article-title":"The importance of patient-reported outcomes in clinical trials and strategies for future optimization","volume":"9","author":"Mercieca-Bebber","year":"2018","journal-title":"Patient Relat. Outcome Meas."},{"key":"10.1016\/j.lungcan.2026.109552_b0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semradonc.2023.07.002","article-title":"Patient-reported outcomes in clinical trials: from an endpoint to an intervention in cancer care","volume":"33","author":"Narra","year":"2023","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2026.109552_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-024-02312-4","article-title":"The use of patient-reported outcome measures to improve patient-related outcomes \u2013 a systematic review","volume":"22","author":"Bonsel","year":"2024","journal-title":"Health Qual. Life Outcome."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:24:41Z","timestamp":1791271481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0169500226006136"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109552","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating health-related quality of life questionnaires in capturing common symptomatic adverse events in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109552"}}